Robotic Aseptic Fill-Finish: A Game-Changing Flexible Solution
Pii’s Robotic Aseptic Fill-Finish
Pii’s Robotic Aseptic Fill-Finish line provides reliable and flexible processing, minimizes manual interventions, and reduces product losses, common at the beginning and end of batch manufacturing. The Robotic Aseptic Fill-Finish line compliments Pii’s larger volume production lines by offering clinical fill-finish manufacturing of cartridges, vials and syringes. With Batch Sizes from 1L – 1000L, Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Pii’s Large Scale Aseptic Fill-Finish
Pii’s Bosch Aseptic Fill-Finish line is perfect for handling large commercialization batches, filling up to 150-200 vials per minute. The Bosch accommodates both Ready to Use (RTU) and Ready to Sterilize (RTS) vials 2mL – 100mL.Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Pii's Aseptic Vial Fill-Finish
Pii’s M and O Perry Aseptic Fill-Finish line offers clinical and commercial fill-finish manufacturing of vials filling up to 40 vials per minute. This line supports batch sizes from (1L – 500L) and the ability to fill a vial size range from 3mL – 100mL. Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Pii’s Aseptic Pre-Filled Syringe Fill-Finish
Pii’s Groninger Syringe Fill-Finish line supports a range of injectables from clinical to commercial batch sizes up to 50,000 syringes per day with pre-filled syringe sizes ranging from 1mL – 10mL. Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Ensuring Quality from the Start: Raw Materials Testing Support
November 21st 2024Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
November 21st 2024Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.
